| Novartis India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 500672 |
NSE Symbol : NOVARTIND |
P/E(TTM) : 50.22 |
|
ISIN Demat : INE234A01025 |
Div & Yield% : 1.26 |
EPS(TTM) : 39.60 |
|
Book Value(₹) : 331.23 |
Market Cap(₹Cr) : 4,910.63 |
Face Value(₹) : 5.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 103.81 | 90.55 | 85.90 | 90.33 | 87.55 | 83.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 103.81 | 90.55 | 85.90 | 90.33 | 87.55 | 83.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 8.74 | 10.01 | 8.75 | 9.40 | 10.61 | 10.63 |
| Total Income | 112.55 | 100.56 | 94.65 | 99.73 | 98.16 | 94.51 |
| Total Expenditure | 68.90 | 69.93 | 63.54 | 66.45 | 60.31 | 59.97 |
| PBIDT | 43.65 | 30.63 | 31.11 | 33.28 | 37.85 | 34.54 |
| Interest | 0.06 | 0.07 | 0.98 | 0.11 | 0.10 | 0.12 |
| PBDT | 43.59 | 30.56 | 30.13 | 33.17 | 37.75 | 34.42 |
| Depreciation | 0.42 | 0.42 | 0.48 | 0.52 | 0.53 | 0.53 |
| Tax | 11.46 | 2.93 | 13.94 | 8.48 | 9.60 | 3.84 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.50 | 1.96 | -0.38 | -0.05 | 0.00 | 0.75 |
| Reported Profit After Tax | 32.21 | 25.25 | 16.09 | 24.22 | 27.62 | 29.30 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 32.21 | 25.25 | 16.09 | 24.22 | 27.62 | 29.30 |
| EPS (Unit Curr.) | 13.05 | 10.23 | 6.52 | 9.81 | 11.19 | 11.87 |
| EPS (Adj) (Unit Curr.) | 13.05 | 10.23 | 6.52 | 9.81 | 11.19 | 11.87 |
| Calculated EPS (Unit Curr.) | 13.05 | 10.23 | 6.52 | 9.81 | 11.19 | 11.87 |
| Calculated EPS (Adj) (Unit Curr.) | 13.05 | 10.23 | 6.52 | 9.81 | 11.19 | 11.87 |
| Calculated EPS (Ann.) (Unit Curr.) | 52.20 | 40.92 | 26.08 | 39.25 | 44.76 | 47.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 52.20 | 40.92 | 26.08 | 39.25 | 44.76 | 47.49 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 | 12.34 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 42.05 | 33.83 | 36.22 | 36.84 | 43.23 | 41.18 |
| PBDTM(%) | 41.99 | 33.75 | 35.08 | 36.72 | 43.12 | 41.03 |
| PATM(%) | 31.03 | 27.89 | 18.73 | 26.81 | 31.55 | 34.93 |
